Report on origins of clinical trial participants updated
10/11/2010 - The European Medicines Agency has published an updated report on the geographical origins of patients included in clinical trials submitted to the Agency in applications for marketing authorisations.
The report now includes information on all applications submitted to the Agency between January 2005 and December 2009. It shows that 61% of the patients in the pivotal clinical trials in marketing authorisation applications came from 'third' countries outside the European Union, European Economic Area and European Free Trade Association.
The report also gives an update on the locations of the investigator sites and clinical trials, as well as the number of clinical trial sites that were inspected and where these inspections took place.